pulmonologyadvisor4h
AHA: GLP-1 RA, SGLT-2i Use Can Lower Risk for MI, Recurrent Stroke in Stroke Survivors
For patients with ischemic stroke, sodium-glucose cotransporter-2 inhibitors (SGLT-2is) and glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are associated with reduced mortality, myocardial ...
Monthly Prescribing Reference1d
SGLT-2 Inhibitors Beneficial for Patients With Nephrolithiasis
Researchers emulated target trials comparing recurrence of nephrolithiasis among patients with preexisting nephrolithiasis initiating SGLT-2 inhibitors vs an active comparator. (HealthDay News) — For ...
clinicaladvisor.com3d
FDA Panel Votes on Sotagliflozin, an Oral Treatment for Type 1 Diabetes
On the question of whether the benefits of sotagliflozin, an oral dual sodium-glucose co-transporter types 1 and 2 (SGLT1/SGLT2) inhibitor, outweigh the risks in this patient population, the committee ...
Critical Gaps in FSGS Treatment Highlight Need for New Therapies, with Pipeline Assets from Travere, Vertex, and Dimerix Poised to Address Unmet Needs
FSGS presents significant management challenges, with nephrologists (n=102) estimating that, on average, nearly half of their patients are not optimally managed with existing therapies. Spherix’s ...
The Bakersfield Californian13d
Critical Gaps in FSGS Treatment Highlight Need for New Therapies, with Pipeline Assets from ...
Focal segmental glomerulosclerosis (FSGS), one of the most common glomerular diseases seen by nephrologists, ranks among the top three rare kidney diseases ...
Endocrinology Advisor14d
SGLT2 Inhibitors Reduce the Risk for Dementia, PD in Patients With Diabetes
Among patients with type 2 diabetes, sodium-glucose cotransporter 2 inhibitor use was linked to reduced risk for neurodegenerative disorders. Sodium-glucose cotransporter 2 (SGLT2) inhibitor use is ...
emjreviews.com15d
SGLT2 Inhibitors More Effective in Reducing Kidney Complications
A RECENT real-world study has found that sodium-glucose cotransporter 2 (SGLT2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists are more effective at reducing kidney complications in ...
Everyday Health15d
What Are COX-2 Inhibitors?
Over-the-counter NSAID medications include aspirin, ibuprofen (Advil, Motrin, and other brand names), and naproxen (Aleve), but selective COX-2 inhibitor NSAIDs are prescription medications that ...
Medpage Today on MSN16d
SGLT2 Inhibitor Carry-Over Benefits Last How Long?
Of note, a similar proportion of patients in the empagliflozin and placebo groups (43% and 40%, respectively) were using an ...
Monthly Prescribing Reference16d
Increases in GLP-1 RA, SGLT2 Inhibitor Use in Type 1 Diabetes in Last Decade
Greatest increase in SGLT2 inhibitor use seen in subgroups with cardiovascular disease; greatest increase in GLP-1 RA for those with obesity. HealthDay News — From 2010 to 2023, there was an ...
Too Old to Operate16d
2010 to 2023 Saw Increase in GLP-1 RA, SGLT2 Inhibitor Use in Type 1 Diabetes
MONDAY, Oct. 28, 2024 (HealthDay News) — From 2010 to 2023, there was an increase in prescribing of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) and sodium glucose cotransporter 2 (SGLT2) ...